Antibodies Against Laminaribioside and Chitobioside Are Novel Serologic Markers in Crohn’s Disease
To access this article, please choose from the options below
Not supported by award or grant.
PII: S0016-5085(06)00842-0
doi:10.1053/j.gastro.2006.04.030
© 2006 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Serologies in Crohn’s Disease: Can We Change the Gray Zone to Black and White?

